Serum Levels of Hepatocyte Growth Factor in Patients with Breast Cancer

@article{SheenChen2005SerumLO,
  title={Serum Levels of Hepatocyte Growth Factor in Patients with Breast Cancer},
  author={Shyr-Ming Sheen-Chen and Yueh-Wei Liu and Hock Liew Eng and F F Chou},
  journal={Cancer Epidemiology Biomarkers \& Prevention},
  year={2005},
  volume={14},
  pages={715 - 717}
}
Objective: Hepatocyte growth factor (HGF) has been reported the cause of many biological events, including cell proliferation, movement, invasiveness, morphogenesis, and angiogenesis. Elevated hepatocyte growth factor content in tumor tissue was reported to predict a more aggressive biology in non–small cell lung cancer patients. However, there is still limited knowledge about the role of HGF in breast cancer. This study was designed with the aim to elucidate the possible relationship between… Expand
Clinical value of serum hepatocyte growth factor, B-cell lymphoma-2 and nitric oxide in primary breast cancer patients.
TLDR
It is demonstrated that the serum levels of HGF, Bcl-2 or NO may help in the diagnosis of breast cancer patients and may aid in disease prognosis, however, larger study with more patients are required. Expand
Serum Levels of Hepatocyte Growth Factor/Scatter Factor in Patients with Liver Metastases from Breast Cancer
TLDR
Serum levels of HGF/SF are associated with the clinical course of metastatic breast cancer patients with liver metastases and its receptor c-Met should be further evaluated as therapeutic targets. Expand
Serum levels of hepatocyte growth factor as a potential tumor marker in patients with malignant melanoma
TLDR
Evaluating the predictive and prognostic value of circulating HGF in terms of treatment outcome and survival compared with a widely established serum marker, protein S-100B, in patients with advanced metastatic melanoma found it to be a useful additional tool in the management of melanoma patients. Expand
Expression of hepatocyte growth factor in breast cancer and its effect on prognosis and sensitivity to chemotherapy.
TLDR
HGF was highly expressed in breast cancer cells and was closely associated with lymph node metastasis, prognosis and sensitivity to chemotherapy, suggesting that HGF may be a potential indicator of the prog outlook and effectiveness of chemotherapy for breast cancer. Expand
Predictive Value of Plasma Hepatocyte Growth Factor/Scatter Factor Levels in Patients with Clinically Localized Prostate Cancer
TLDR
Preoperative plasma level of HGF/SF is an independent predictor of prostate cancer metastasis to lymph nodes and disease recurrence after surgery, and may help in therapeutic decision-making and enrollment into clinical trials. Expand
Hepatocyte growth factor in Egyptian females with breast benign lumps and cancers.
TLDR
The serum level of HGF is an independent prognostic indicator for breast cancer after significant increase was found in patients with benign breast lumps and in breast cancer patients when each was compared to controls and when cancer patients were compared to the benign breastLumps group. Expand
Localized Prostate Cancer Factor / Scatter Factor Levels in Patients with Clinically Predictive Value of Plasma Hepatocyte Growth
Purpose: Hepatocyte growth factor/scatter factor (HGF/SF) is a multifunctional cytokine that is involved in cancer growth, motility, invasion, and angiogenesis.We assessed whether preoperative plasmaExpand
Quantification of angiogenic factors and their clinicopathological associations in breast cancer
TLDR
The significant elevation in serum levels of VEGF-A, EGF, and PDGF-AA serum levels in BC patients suggests these cytokines might have diagnostic value as potential biomarkers in BC. Expand
Expression of Hepatocyte Growth Factor and Basic Fibroblast Growth Factor as Prognostic Indicators in Gastric Cancer
TLDR
Both HGF and bFGF may participate in angiogenesis in gastric cancer and may be involved in tumor invasion and metastasis and can be used as useful parameters to evaluate the prognosis of Gastric cancer. Expand
Significance of Serum HGF, Bcl-2 and Nitric Oxide in Primary Breast Cancer
TLDR
It is demonstrated that the serum determination of HGF, Bcl-2 or NO may help in diagnosis of the breast cancer and may aid in disease prognosis and larger studies with more patients are required. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 29 REFERENCES
The clinical significance of hepatocyte growth factor for non-small cell lung cancer.
TLDR
The data indicate that HGF is also a negative prognostic indicator in lung cancer and may be useful as an indicator of high risk in early stage lung cancer patients, and suggests that elevated HGF may predict a more aggressive biology in non-small cell lung cancer Patients. Expand
Serum concentration of tumor necrosis factor in patients with breast cancer
TLDR
Preoperative evaluation of serum tumor necrosis factor alpha concentrations maybe a valuable parameter for reflecting the severity of staging for invasive breast cancer, and predicting the significant, higher serum concentration of tumor necrosisfactor alpha. Expand
Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines.
TLDR
Investigation of immunoreactive (ir)-HGF concentration in tumor extracts of 82 primary human breast cancers using an enzyme-linked immunosorbent assay (ELISA) found that the ir-HGF level was significantly higher in tumors with sizes of more than 5.0 cm, suggesting that the cancer cell itself has no ability to produce ir- HGF. Expand
Serum-soluble interleukin-2 receptor concentrations in patients with breast cancer: a preliminary report.
TLDR
The preoperative serum-soluble interleukin-2 receptor concentration is closely related to lymph node status, distant metastasis status and tumor diameter in invasive breast carcinoma, and may be an additional valuable predictive factor for the diagnosis of invasive breast cancer. Expand
Increase in the circulating level of hepatocyte growth factor in gastric cancer patients.
TLDR
The circulating levels of HGF were elevated in approximately one-third of patients with primary gastric cancer, particularly in those with high grades of histological tumour invasion and venous invasion, and frequently in patients with distant metastases, suggesting that HGF might play important roles in the tumour progression of gastriccancer. Expand
Serum levels of circulating intercellular adhesion molecule-1 in patients with breast cancer.
TLDR
Preoperative serum levels of circulating intercellular adhesion molecule-1 may reflect the severity of staging for invasive breast cancer and may be a promising, additive predictor which deserves further investigation. Expand
Evaluation of the prognostic value of serum soluble CD 44 in patients with breast cancer.
TLDR
Based on the preliminary results, preoperative serum soluble CD 44 V6 is closely related to distant metastases and TNM staging and deserves further elucidation and evaluation with long-term patient follow-up. Expand
Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
TLDR
There are mutual interactions between carcinoma cells and fibroblasts: IL-1, bFGF, and platelet-derived growth factor derived from tumor cells play a role in inducing HGF expression in stromal fibro Blasts, whereas fibroblast-derived HGF, in turn, leads to invasive growth in carcinoma Cells. Expand
The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer.
TLDR
The PCNA-labeling index potentially is a useful prognostic factor for lymph node-positive primary breast cancer and when all the clinicopathologic variables were entered into a multivariate analysis for either disease-free survival or overall survival by the Cox proportional hazards model, it emerged as an independent prognostic factors. Expand
Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors.
TLDR
It is shown that several adult human primary fibroblast cultures from breast and prostate produce HGF/SF, and that MRC-5 HGF expression is inhibited by several known peptide growth factors, including transforming growth factor beta, epidermal growth factor, and transforming growth factors alpha. Expand
...
1
2
3
...